Aristides Capital LLC Champions Oncology, Inc. Transaction History

Aristides Capital LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 13, 2024	SELL	$4.56 - $6.59 $44,687 - $64,582	-9,800 Reduced 45.32%	11,822 $66,000
Q4 2022 Feb 14, 2023	SELL	$3.75 - $7.69 $56,730 - $116,334	-15,128 Reduced 41.16%	21,622 $97,000
Q1 2021 May 17, 2021	SELL	$10.61 - $13.75 $34,482 - $44,687	-3,250 Reduced 8.13%	36,750 $415,000
Q4 2020 Feb 12, 2021	BUY	$8.39 - $13.27 $335,600 - $530,800	40,000 New	40,000 $432,000

5.82M

15K

Ticker CSBR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 13,522,400
Market Cap $102M
Description
Champions Oncology, Inc. develops and sells technology solutions and products to personalize the development and use of oncology drugs in the United States. Its Tumorgraft Technology Platform is an approach to personalizing cancer care based upon the implantation of human tumors in immune-deficient mice. The company, through its Tumorgraft Techn...

Get notified when there are updates to the investment portfolio of Aristides Capital LLC, based on Form 13F filings with the SEC.

Stay updated on Aristides Capital LLC with notifications on news.